RNWCX
Price
$87.62
Change
-$0.11 (-0.13%)
Updated
Jul 18 closing price
Net Assets
70.21B
RNWHX
Price
$88.24
Change
-$0.11 (-0.12%)
Updated
Jul 18 closing price
Net Assets
70.21B
Interact to see
Advertisement

RNWCX vs RNWHX

Header iconRNWCX vs RNWHX Comparison
Open Charts RNWCX vs RNWHXBanner chart's image
American Funds New World R3
Price$87.62
Change-$0.11 (-0.13%)
VolumeN/A
Net Assets70.21B
American Funds New World R5E
Price$88.24
Change-$0.11 (-0.12%)
VolumeN/A
Net Assets70.21B
RNWCX vs RNWHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RNWCX vs. RNWHX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWCX is a Buy and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWCX (70.2B) and RNWHX (70.2B) have equal amount of cash in the bank . RNWHX pays higher dividends than RNWCX: RNWHX (0.99) vs RNWCX (0.52). RNWCX was incepted earlier than RNWHX: RNWCX (23 years) vs RNWHX (10 years). RNWCX (1.22) is less costly to investors than RNWHX (0.72). RNWCX (37.00) and RNWHX (37.00) have comparable annual turnover. RNWCX (250) and RNWHX (250) have matching initial minimum investment requirements. RNWHX (12.04) and RNWCX (11.48) have marching annual gain over last year. RNWHX return over 5 years is better than : 29.06 vs. RNWCX (26.93).
RNWCXRNWHXRNWCX / RNWHX
Total Expense Ratio1.220.72169%
Annual Report Gross Expense Ratio1.220.72169%
Fund Existence23 years10 years-
Gain YTD15.76216.07598%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets70.2B70.2B100%
Annual Yield % from dividends0.520.9953%
Returns for 1 year11.4812.0495%
Returns for 3 years36.8738.2097%
Returns for 5 years26.9329.0693%
Returns for 10 years64.27N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESTC86.790.49
+0.57%
Elastic NV
ENTO0.47N/A
-0.08%
Entero Therapeutics Inc.
HTH31.29-0.06
-0.19%
Hilltop Holdings
XOS3.37-0.09
-2.60%
Xos
CGEM7.53-0.24
-3.09%
Cullinan Therapeutics